Many small game companies share a fear of one big game developer: Zynga, the publicly traded maker of popular games like FarmVille and Words With Friends.
In 1997, KPR merged with Ryka Inc., a publicly traded maker of athletic footwear for women; the company later became Global Sports.
Dr. Glimcher was also paid $238,545 in cash, stock and options in 2010 by the Waters Corporation, a publicly traded maker of lab equipment, according to a company filing in March.
In 1981 he doubled the size of the company by buying Aegis, a publicly traded maker of cruisers, runabouts and fishing boats.
Black Duck Software, a 15-year-old company whose products automate the process of securing and managing open-source software — including detecting license compliance issues — is being acquired by Synopsys, the publicly traded maker of semiconductor-design software.
DP: Dollar Shave Club was acquired by Unilever for $1 billion [last summer], Receptos [a publicly traded maker of autoimmune drugs] sold to the cancer drug company Celgene for $7.2 billion [in July 2015], and Juno Therapeutics had a successful IPO [in December 2014].
"It was Kevin's expectation to have done something by now," another general manager said of Kevin Malone, the Dodgers' trade-maker, "but every time the outfielder opens his mouth, it makes his task tougher".
Zhang Dejiang, the party secretary of Guangdong Province, will assume Wu Yi's portfolio as the country's trade policy maker and troubleshooter who coordinates responses to medical and safety problems.
Fair trade soap maker Bubble & Balm went bust after raising £75,000 ($121,533) from 82 investors on Crowdcube, one of the UK's largest equity crowdfunding players, in July 2011.
This led to specific 'product pathways', which can be further refined and used by health policy-makers to engage with their country's trade policy-makers around health impacts of ongoing trade treaty negotiations, and by researchers to continue refining an evidence base on how global trade is affecting patterns of chronic disease.
This led to specific 'product pathways', which we propose can be further refined and used by health policy-makers to engage with their country's trade policy-makers around health impacts of ongoing trade treaty negotiations, and by researchers to continue refining an evidence base on how global trade is affecting patterns of chronic disease.
